Related Experiment Video
Updated: Jun 15, 2026
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Multiple cytokine biomarkers in heart failure
Maria Vistnes1, Geir Christensen, Torbjørn Omland
1Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway.
Expert Review of Molecular Diagnostics
|March 11, 2010
Summary
Analyzing multiple cytokines in heart failure patients can improve risk stratification and personalized treatment. Multiplexing technologies like Luminex offer a comprehensive view of immune activation for better heart disease management.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Biomarker Discovery
Background:
- Elevated proinflammatory cytokines correlate with chronic heart failure progression and poor outcomes.
- Cytokine profiles vary by heart failure etiology, suggesting potential for subgroup classification.
- Current understanding of cytokine release in heart disease is limited, hindering clinical application.
Purpose of the Study:
- To explore the potential of simultaneous cytokine measurements for enhanced heart failure risk stratification.
- To investigate the utility of multiplex cytokine analysis for personalized heart failure therapy.
- To highlight the need for bioinformatic tools to interpret complex cytokine profiles in heart disease.
Main Methods:
- Simultaneous measurement of multiple cytokines using multiplex protein analysis platforms, such as Luminex technology.
- Analysis of cytokine blood levels to understand immune activation in heart failure.
- Review of current technological advancements in multiplex cytokine assays.
Main Results:
- Multiplex cytokine analysis provides a more comprehensive picture of immune activation compared to single assays.
- Cytokine profiles differ based on the initiating cause and type of heart failure.
- Technological advancements have made multiplex cytokine measurement simple, fast, and reproducible.
Conclusions:
- Subclassification of heart failure patients by cytokine measurements could enable tailored therapies.
- Multiplex protein analyses are crucial for future heart failure research and clinical practice.
- Further research and bioinformatic tools are needed to fully implement multimarker cytokine approaches in clinical settings.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...